- Center on Health Equity and Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
Participating Faculty
The American Journal of Managed Care
This supplement to contains information on otitis media and its impact on managed care.
Faculty
Diana I. Brixner, RPh, PhD
Department of Pharmacotherapy
Pharmacotherapy Outcomes Research Center
Professor, Microbiology and Immunology, Pediatrics and Medicine
Rochester, New York
Disclosure Statement
The American Journal of Managed Care
It is the policy of to have all faculty who participate in programs sponsored by pharmaceutical companies disclose any real or apparent conflicts of interest.
These participants report relationships with the following pharmaceutical companies:
Diana I. Brixner, RPh, PhD
Grant/Research Support From:
- Aventis
- Boehringer-Ingelheim
- Genzyme
- TAP
Speaker or Consultant To:
- Amgen
- Bristol-Myers Squibb
- NPS
- TAP
Michael E. Pichichero, MD
Grant/Research Support From:
- Abbott
- Eli Lilly
- Johnson & Johnson
- Sanofi-Aventis
CME Speaker For or Ad Hoc Consultant To:
- Bristol-Myers Squibb
- GlaxoSmithKline
- Sanofi-Aventis
The American Journal of Managed Care,
Signed disclosures are on file at the offices of Jamesburg, New Jersey.
This program is supported by an educational grant from Abbott.
The contents of this supplement may include information regarding the use of products that may be inconsistent outside the approved labeling for these products in the United States. Physicians should note that the use of these products outside current approved labeling is considered experimental and are advised to consult prescribing information for these products.
